Barriers to vaccination in renal transplant recipients

Maldonado, Angela Q.; Johnson, David G.; Trofe‐Clark, Jennifer

doi:10.1111/tid.12749

Cited by 3 publications

(2 citation statements)

References 31 publications

(54 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Barriers to missed opportunities for vaccination from the patient's perspective were not able to be explored due to the retrospective nature of this study. Other studies have interviewed patients that were successfully (or unsuccessfully) vaccinated and identified barriers including financial coverage, timing and access to vaccinations, age‐related barriers, and liability of follow‐up from the multi‐disciplinary team …”

Section: Discussionmentioning

confidence: 99%

Infectious diseases pre‐transplant evaluation improves vaccination rates for liver transplant candidates

Pineda

Spinner

Pallotta

et al. 2019

Transplant Infectious Dis

View full text Add to dashboard Cite

Immunization rates in pre-liver transplant patients have been historically below rates for immunocompetent patients. At Cleveland Clinic, an infectious diseases (ID) consult is required for all patients during the liver transplant evaluation and may beneficially impact vaccination rates. The goal of this study was to evaluate pre-transplant vaccination rates in pre-liver transplant candidates. This single-center, retrospective chart review included adults transplanted between January 1, 2013, and December 31, 2016. Prior to transplant, rates of vaccination and/or documented seropositivity were 35% for hepatitis B vaccine, 92% for hepatitis A vaccine, 57% for pneumococcal conjugate vaccine, 62% for pneumococcal polysaccharide vaccine, and 77% for influenza vaccine. Vaccination rates were higher than to previously reported. Rates were also higher for several vaccines compared to transplant candidates for other organs without ID consult. With ongoing ID consult requirements for liver transplant candidates, combined with standardization of vaccine recommendations via technology, and increased multi-disciplinary collaboration, vaccination rates should improve further. K E Y W O R D Sinfectious diseases, liver transplant, vaccine

show abstract

Section: Discussionmentioning

confidence: 99%

Infectious diseases pre‐transplant evaluation improves vaccination rates for liver transplant candidates

Pineda

Spinner

Pallotta

et al. 2019

Transplant Infectious Dis

View full text Add to dashboard Cite

show abstract

“…Many studies have cited multifactorial causes of barriers to vaccination in solid organ transplants, including financial coverage for vaccination, fear of allograft rejection and other adverse effects, lack of knowledge and access to healthcare, vaccine unavailability, lack of coordination between transplant teams, low priority for vaccination, and late evaluation for vaccination (precluding use of live vaccines in those who are likely to get transplant soon). 16 , 17 , 22 , 23 Based on our study, intentional consultation of pre-KT recipients offers an opportunity to address potential barriers and maximize opportunity for immunization against vaccine preventable illnesses in a vulnerable population. Access to immunization in transplant specific clinics is another way of increasing immunization rates.…”

Section: Discussionmentioning

confidence: 99%

Vaccination in Kidney Transplant Candidates

Gajurel,

Ngo,

Fairman

et al. 2023

Transplantation Direct

View full text Add to dashboard Cite

Background: Kidney transplant (KT) candidates have historically low immunization rates against recommended vaccines. A retrospective single-center study of contemporary KT candidates was conducted to assess vaccination rates and vaccine uptake. Methods: All KT candidates ≥18 y evaluated between January 1, 2020, and December 31, 2020, were retrospectively reviewed for history of prior vaccination against tetanus, diphtheria, and pertussis; 13-valent pneumococcal conjugate vaccine; 23-valent pneumococcal polysaccharide vaccine; and recombinant zoster vaccine. Positive hepatitis A IgG total, hepatitis B surface antibody, measles, mumps, rubella, and varicella IgG were assessed as surrogate markers of immunity. Vaccine uptake among vaccine-eligible candidates was also assessed. Results: Among 150 KT candidates, the rate of prior vaccination against tetanus, diphtheria, and pertussis; 13-valent pneumococcal conjugate vaccine; 23-valent pneumococcal polysaccharide vaccine; and recombinant zoster vaccine (latter among patients ≥50 y) was found to be as low as 11%. Hepatitis A IgG total, hepatitis B surface antibody, measles, mumps, rubella, and varicella IgG seropositivity rates were 30%, 66%, 88%, 78%, 90%, and 96%, respectively. Only 7 (5%) of 150 patients had complete immunization or seropositivity. Five (3%) of 143 vaccine-eligible patients declined vaccination. Hepatitis A vaccine declination was relatively common with 15 (16%) of 94 vaccine-eligible patients declining it. Conclusions: KT candidates have low baseline rates of prior immunization/seropositivity against most recommended vaccines. Overall vaccine uptake among eligible candidates was high.

show abstract

Entrustable professional activities for pharmacy students: A primer for solid organ transplant preceptors

Lichvar

Chandran

et al. 2021

American Journal of Health-System Pharmacy

View full text Add to dashboard Cite

Disclaimer In an effort to expedite the publication of articles , AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose The role of a solid organ transplant pharmacist is multifaceted and translates to diverse experiential and elective learning experiences that can be provided to pharmacy learners. Here we provide a guide to integrating pharmacy students into patient care and other pharmacist activities in solid organ transplantation. Summary Thoughtful incorporation of learners into clinical practice and clinical research creates a positive learning environment for pharmacy students that can foster the development of core skills necessary for students to become “practice-ready” and “team-ready” pharmacy graduates and can equip them with valuable skills to incorporate into the specialty practice areas and careers they pursue. To help develop these educational experiences, attention to the list of core entrustable professional activities (EPAs) established by the American Association of Colleges of Pharmacy can help create a rich environment of learning with carefully cultivated tasks. Furthermore, learners can serve as transplant pharmacist extenders to assist in overall patient care and multidisciplinary involvement on the transplant team. This article serves as a “how-to” guide for applying the EPA framework to integrating pharmacy students in patient care and other pharmacist activities in solid organ transplantation and other specialty practice areas. Conclusion As pharmacy preceptors design and operationalize their teaching to incorporate EPAs, they can benefit from recommendations tailored to specialty practice areas such as solid organ transplantation. Students may start and finish these experiences at different EPA levels, but continuance of training will allow them to achieve the final EPA level across the 6 EPA domains.

show abstract

Barriers to vaccination in renal transplant recipients

Cited by 3 publications

References 31 publications

Infectious diseases pre‐transplant evaluation improves vaccination rates for liver transplant candidates

Infectious diseases pre‐transplant evaluation improves vaccination rates for liver transplant candidates

Vaccination in Kidney Transplant Candidates

Entrustable professional activities for pharmacy students: A primer for solid organ transplant preceptors

Contact Info

Product

Resources

About